Publikationen, an denen er mitarbeitet Elisa Vidal Verdú (13)

2024

  1. Isavuconazole Versus Voriconazole as the First-line Therapy for Solid Organ Transplant Recipients With Invasive Aspergillosis: Comparative Analysis of 2 Multicenter Cohort Studies

    Transplantation, Vol. 108, Núm. 11, pp. 2260-2269

  2. Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update

    Transplantation Reviews, Vol. 38, Núm. 4

2023

  1. Isavuconazole for the Treatment of Invasive Mold Disease in Solid Organ Transplant Recipients: A Multicenter Study on Efficacy and Safety in Real-life Clinical Practice

    Transplantation, Vol. 107, Núm. 3, pp. 762-773

2021

  1. Invasive aspergillosis in solid organ transplantation: Diagnostic challenges and differences in outcome in a Spanish national cohort (Diaspersot study)

    Mycoses, Vol. 64, Núm. 11, pp. 1334-1345

2020

  1. Executive summary of the Consensus Statement of the Transplant Infection Study Group (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the National Transplant Organization (ONT) on the Selection Criteria of Donors of Solid Organs in relation to Infectious Diseases

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 8, pp. 379-389

  2. Selection criteria of solid organ donors in relation to infectious diseases: A Spanish consensus

    Transplantation Reviews, Vol. 34, Núm. 2

2019

  1. Regular monitoring of cytomegalovirus-specific cell-mediated immunity in intermediate-risk kidney transplant recipients: predictive value of the immediate post-transplant assessment

    Clinical Microbiology and Infection, Vol. 25, Núm. 3, pp. 381.e1-381.e10

2018

  1. Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations

    Transplantation Reviews, Vol. 32, Núm. 1, pp. 36-57

2016

  1. Management of cytomegalovirus infection in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations

    Transplantation Reviews, Vol. 30, Núm. 3, pp. 119-143

2015

  1. Influenza vaccination during the first 6 months after solid organ transplantation is efficacious and safe

    Clinical Microbiology and Infection, Vol. 21, Núm. 11, pp. 1040.e11-1040.e18

2012

  1. Bacterial urinary tract infection after solid organ transplantation in the RESITRA cohort

    Transplant Infectious Disease, Vol. 14, Núm. 6, pp. 595-603

  2. Pandemic influenza A(H1N1) virus infection in solid organ transplant recipients: Impact of viral and non-viral co-infection

    Clinical Microbiology and Infection, Vol. 18, Núm. 1, pp. 67-73

2005

  1. Documento de consenso GESIDA/GESITRA-SEIMC, SPNS y ONT sobre trasplante de órgano sólido en pacientes infectados por el VIH en España (Marzo 2005)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 23, Núm. 6, pp. 353-362